Categories: News

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2025 will be released before markets open on Thursday, May 8th.

Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, May 8th to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 63341. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will be archived for future reference.

Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com

About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com

Staff

Recent Posts

Dr. Christina Rahm’s Merci Dupre Clothiers Presents Revolutionary Eco-Fashion Show Tonight in Spartanburg, SC

Spartanburg, South Carolina--(Newsfile Corp. - May 9, 2025) - Dr. Christina Rahm, renowned scientist, humanitarian,…

3 hours ago

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one…

5 hours ago

Artificial Intelligence (AI) in Healthcare Market worth US$110.61 billion by 2030 with 38.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 9, 2025 /PRNewswire/ -- The global Artificial Intelligence (AI) in Healthcare…

6 hours ago

Airmedic Selects ImageTrend to Strengthen Aeromedical Response Across Québec

EAGAN, Minn., May 9, 2025 /PRNewswire/ -- ImageTrend, a leading provider of cloud-based software solutions…

6 hours ago

Verseon Presents Two AI Innovations at the 2025 IEEE Conference on Artificial Intelligence

One Verseon paper covers a new method to compensate for missing or imperfect data and…

6 hours ago